Nanomedicine News

RSS

New Lab on a Chip Device Developed to Diagnose HIV Infection

UC Davis biomedical engineer Prof. Alexander Revzin has developed a "lab on a chip" device for HIV testing.

17 Jul 2010

Magnetic Nanoparticles Selectively Bind to and Remove Ovarian Tumor Cells from Abdominal Cavity Fluid

A major complicating factor in the treatment of ovarian cancer is that malignant cells are often shed into the patient’s abdominal cavity. These cells can then spread to other tissues, seeding new tumors that make ...

16 Jul 2010

In Vivo Assembly of Nanoparticle Components to Improve Targeted Cancer Imaging

Virtually every study that uses nanoparticles to deliver drugs and imaging agents to tumors starts by loading the clinical payload into the nanoparticle and then injecting the resulting delivery agent into the body. Whil...

16 Jul 2010

Nanosponge Delivers Sustained, Specific Release of Paclitaxel to Irradiated Tumors

When loaded with an anticancer drug, a delivery system based on a novel material that its creators call a nanosponge is three to five times more effective at reducing tumor growth than direct injection of the same drug. That is the conclusion of a paper published in the journal Cancer Research.

16 Jul 2010

Sugar-Coated Nanocapsule Delivers Large Doses of Radioactivity to Tumors

Starting with simple carbon nanotubes, a team of researchers from the United Kingdom and Spain has developed a sugar-coated nanocapsule that can deliver large doses of radioactivity to tumors. The researchers envision de...

16 Jul 2010

Tekmira to Advance RNAi Therapeutic Using Lipid Nanoparticle Technology

Tekmira Pharmaceuticals Corporation (TSX: TKM), a leader in RNA interference (RNAi) therapeutics, today announced that it has been awarded a new contract with the United States Department of Defense (DoD) Chemical and Biological Defense Program (CBDP) through the U.S. Army Space and Missile Defense Command (SMDC).

16 Jul 2010